KDM1A and colorectal carcinoma: Ding et al. found that miR-137-3p was poorly expressed in CRC, whereas inhibition of miR-137-3p upregulated KDM1A expression and promoted CRC cell invasiveness, and genetic or pharmacological inhibition of KDM1A reduced hypoxia-induced CRC cell migration and invasion by suppressing EMT [95].